Identification of SLAMF3 (CD229) as an inhibitor of hepatocellular carcinoma cell proliferation and tumour progression.

Although hepatocellular carcinoma (HCC) is one of the most common malignancies and constitutes the third leading cause of cancer-related deaths, the underlying molecular mechanisms are not fully understood. In the present study, we demonstrate for the first time that hepatocytes express signalling l...

Full description

Bibliographic Details
Main Authors: Ingrid Marcq, Rémy Nyga, Flora Cartier, Rabbind Singh Amrathlal, Christèle Ossart, Hakim Ouled-Haddou, Hussein Ghamlouch, Antoine Galmiche, Denis Chatelain, Luciane Lamotte, Véronique Debuysscher, Vincent Fuentes, Eric Nguyen-Khac, Jean-Marc Regimbeau, Jean-Pierre Marolleau, Sylvain Latour, Hicham Bouhlal
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3869749?pdf=render